Form D · Biotechnology
Vesicor Therapeutics, Inc.
San Gabriel, CA · CIK 0001993074
Offering snapshot reported May 14, 2025 · SEC filing
- Reported sold
- $515K Offering amount: $3M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $20K Reported outside-investor minimum
- First sale
- Jul 3, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 14, 2025 | Initial | $515,000 | No comparison | 12 | SEC filing |
| Sep 14, 2023 | Initial | $200,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $300K (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-546051
Common Stock and Warrants to Purchase Common Stock
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Altitude Capital Group LLC | 000325198 |
Source: Form D, filed May 14, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Bowen | Executive |
| Luo Feng | Director, Executive |
| Warren Jr. Hosseinion | Executive |
| Warren Hosseinion | Director |
| Warren Hosseinionn | Director |
| Oded Levy | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
207 S. Santa Anita Street, Suite P 15
San Gabriel, CA, 91776
San Gabriel, CA, 91776